APA (7th ed.) Citation

S, B., & KK, R. (2026). Repurposing approved drugs as potential inhibitors of Mycobacterium tuberculosis ClpP: Structure-based virtual screening, molecular dynamics, and in vitro evaluation. Molecular diversity, 30(4), 5621. https://doi.org/10.1007/s11030-025-11452-8

Chicago Style (17th ed.) Citation

S, Bhardwaj, and Roy KK. "Repurposing Approved Drugs as Potential Inhibitors of Mycobacterium Tuberculosis ClpP: Structure-based Virtual Screening, Molecular Dynamics, and in Vitro Evaluation." Molecular Diversity 30, no. 4 (2026): 5621. https://doi.org/10.1007/s11030-025-11452-8.

MLA (9th ed.) Citation

S, Bhardwaj, and Roy KK. "Repurposing Approved Drugs as Potential Inhibitors of Mycobacterium Tuberculosis ClpP: Structure-based Virtual Screening, Molecular Dynamics, and in Vitro Evaluation." Molecular Diversity, vol. 30, no. 4, 2026, p. 5621, https://doi.org/10.1007/s11030-025-11452-8.